[The therapy of edematous diseases].
In the first part the pathogenetic factors of the various edematous diseases are discussed, especially the pathogenesis of cardiac, hepatic, renal and idiopathic edemas. In the second part the therapy of edematous diseases is discussed, especially the effects, side effects, indications and contraindications of diuretics and mineralocorticoid antagonists.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001510:Bed Rest; D003919:Diabetes Insipidus / Q000188:drug therapy; D004232:Diuretics / Q000627:therapeutic use; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D004487:Edema / Q000517:prevention & control*; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000628:therapy; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006993:Hypnotics and Sedatives / Q000506:poisoning; D007008:Hypokalemia / Q000139:chemically induced; D008103:Liver Cirrhosis / Q000188:drug therapy; D000451:Mineralocorticoid Receptor Antagonists; D010406:Penicillins / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D004234:Diuretics, Osmotic; D006993:Hypnotics and Sedatives; D000451:Mineralocorticoid Receptor Antagonists; D010406:Penicillins; D005665:Furosemide; D004976:Ethacrynic Acid
Zur Therapie der Odemkrankheiten.